Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 41Recruiting 31Unknown 15Terminated 7Not yet recruiting 5Active not recruiting 5Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1CNS 1Breast 1

Conditions

Breast Neoplasms 46Triple Negative Breast Neoplasms 10Colorectal Neoplasms 6Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vulvar Neoplasms 1Vaginitis 1Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Osteosarcoma 1Multiple Myeloma 1Margins of Excision 1Lymphedema 1Liver Neoplasms 1Hypertension 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Liver Neoplasms × Breast × Clear all
NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Envita Medical Center, Inc.

Phase 1 Suspended
24 enrolled
BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡